Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
John Pruitt
Observed names:
J Pruitt,
John W. Pruitt
Institution:
LabCorp (United States)
Observed institutions:
Louisiana State University,
University of Washington,
LabCorp (United States),
Northwest Medical Specialties,
Covance (United States),
Louisiana State University Health Sciences Center Shreveport
show all 6
OpenAlex ID:
A5110017674
The Antisense Oligonucleotide Nusinersen for Treatment of Spinal Muscular Atrophy
2021
·
Amber N. Edinoff
, Long H. Nguyen
, et al.
·
Orthopedic Reviews
·
48
PDF
A program for real-time surveillance of SARS-CoV-2 genetics
2024
·
Hayden N. Brochu
, Kuncheng Song
, et al.
·
Scientific Reports
·
6
PDF
SARS-CoV-2 variant introduction following spring break travel and transmission mitigation strategies
2024
·
Justin M. Napolitano
, Sujata Srikanth
, et al.
·
PLoS ONE
·
1
Abstract 4628: Validation of an automated, scalable comprehensive genomic profiling assay for hematologic malignancies
2024
·
Grant Hogg
, Tong Liu
, et al.
·
Cancer Research
·
1
Abstract 498: Meta-analysis of genomic aberrations identified in CTCs andctDNA in triple negative breast cancer
2016
·
Kellie Howard
, Sharon Austin
, et al.
·
Cancer Research
·
1
Abstract 3831: Validation of blood tumor mutation burden in Labcorp Plasma Complete
2026
·
Vito Caropreso
, Kenneth C. Valkenburg
, et al.
·
Cancer Research
Validation of an Automated, Scalable Comprehensive Genomic Profiling Assay for Hematologic Malignancies
2023
·
Grant Hogg
, Tong Liu
, et al.
·
Blood
PDF
Abstract 6220: Development of a mutation profiling NGS assay to facilitate clinical decisions in hematologic malignancies
2023
·
Grant Hogg
, Tong Liu
, et al.
·
Cancer Research
Abstract 2757: Using liquid biopsies and NGS as tools to analyze mutation burden and copy number variation in the blood of a patient with triple negative breast cancer to better inform therapeutic targets
2017
·
Kellie Howard
, Kimberly Kruse
, et al.
·
Cancer Research
Abstract P2-02-21: Longitudinal analysis of circulating tumor cells and cell free tumor DNA by next generation sequencing in triple negative breast cancer
2016
·
K Howard
, S Austin
, et al.
·
Cancer Research
Show more works
View as search
Works count:
10
Citation count:
57
H-index:
2
I10-index:
1
Year
Topic
Type